Search Result "gefitinib (Iressa)"
Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters
Journal: Current Drug Delivery
Volume: 14 Issue: 2 Year: 2017 Page: 282-288
Author(s): Can Zhao,Shu-Yan Han,Ping-Ping Li
Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes
Journal: Drug Metabolism Letters
Volume: 7 Issue: 2 Year: 2013 Page: 126-136
Author(s): Prashant Surve,Selvan Ravindran,Arghya Acharjee,Himanshu Rastogi,Sudipta Basu,Pradnya Honrao
Prospective Study of the Treatment of Biotin in Patients with Drug Erythema due to Gefitinib or Erlotinib
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Yoshikazu Ogawa,Takayoshi Kiba,Kikuo Nakano,Sayoko Kajiume,Yuko Okada,Yasunori Ichiba
Doi: 10.2174/9781681080239117010040
A Role for SNX1 in the Regulation of EGF-Dependent Phosphorylated EGFR Endocytosis Via the Early/Late Endocytic Pathway in a Gefitinib-Sensitive Human Lung Cancer Cells
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 383-395
Author(s): Yukio Nishimura, Kiyoko Yoshioka, Soichi Takiguchi, Biborka Bereczky, Yusaku Nakabeppu, Kazuyuki Itoh
Gefitinib: An Updated Review of its Role in the Cancer Management, itsNanotechnological Interventions, Recent Patents and Clinical Trials
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 448-469
Author(s):
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 5 Year: 2014 Page: 646-650
Author(s): Antonio Passaro, Daniele Alesini, Alessia Pochesci, Enrico Cortesi
Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 176-191
Author(s): R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio, M. Casto
Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer
Journal: Current Computer-Aided Drug Design
Volume: 14 Issue: 3 Year: 2018 Page: 246-252
Author(s): Pulakuntla Swetha Reddy,Kiran Bharat Lokhande,Shuchi Nagar,Vaddi Damodara Reddy,P. Sushma Murthy,K. Venkateswara Swamy
Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside
Journal: Current Respiratory Medicine Reviews
Volume: 3 Issue: 2 Year: 2007 Page: 159-167
Author(s): Alessia Catassi, Alfredo Cesario, Pierluigi Granone, Patrizia Russo
Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in Non- Small Cell Lung Cancer (NSCLC)
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 1 Year: 2006 Page: 1-13
Author(s): Giulio Metro, Giovanna Finocchiaro, Luca Toschi, Stefania Bartolini, Elisabetta Magrini, Alessandra Cancellieri, Rocco Trisolini, Luciano Castaldini, Giovanni Tallini, Lucio Crino, Federico Cappuzzo